RAP 0.00% 20.5¢ resapp health limited

Rap revenue phase, page-31

  1. 26,797 Posts.
    lightbulb Created with Sketch. 1737
    Since RAP has 3x the products in acute respiratory diagnosis, chronic respiratory management and OSA, all massive market......3x the revenue will be "understandable".
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.